Ipilimumab for Patients With Advanced Mucosal Melanoma

The outcome of patients with mucosal melanoma treated with ipilimumab is not defined. To assess the efficacy and safety of ipilimumab in this melanoma subset, we performed a multicenter, retrospective analysis of 33 patients with unresectable or metastatic mucosal melanoma treated with ipilimumab. T...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2013-06, Vol.18 (6), p.726-732
Hauptverfasser:	Postow, Michael A., Luke, Jason J., Bluth, Mark J., Ramaiya, Nikhil, Panageas, Katherine S., Lawrence, Donald P., Ibrahim, Nageatte, Flaherty, Keith T., Sullivan, Ryan J., Ott, Patrick A., Callahan, Margaret K., Harding, James J., D'Angelo, Sandra P., Dickson, Mark A., Schwartz, Gary K., Chapman, Paul B., Gnjatic, Sacha, Wolchok, Jedd D., Hodi, F. Stephen, Carvajal, Richard D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antibodies, Monoclonal - administration & dosage Antigens, Neoplasm - biosynthesis Cancer‐testis antigens Clinical Trials as Topic CTLA-4 Antigen - biosynthesis CTLA‐4 Female Humans Immunotherapy Ipilimumab Male Melanoma - drug therapy Melanoma - pathology Melanoma and Cutaneous Malignancies Middle Aged Mucosal melanoma Mucous Membrane - drug effects Mucous Membrane - pathology Neoplasm Metastasis - drug therapy Neoplasm Metastasis - pathology Retrospective Studies Skin Neoplasms - drug therapy Skin Neoplasms - pathology Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!